Delivery Order SPE2DB24D2101-SPE2DB25FKNDU
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Clarithromycin 500 mg tablets (60-count units) under a firm fixed price contract. The award, issued on September 3, 2025, carries a ceiling value of $1,219.55 and is set to be completed by September 4, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract...
- AmerisourceBergen Drug Corp was awarded a delivery order on June 27, 2025, by the Medical Supply Chain division of the Defense Logistics Agency to supply Clarithromycin ER 500 mg tablets in a 60-count configuration. This firm fixed-price delivery order, valued at $2,362.78, represents a non-set-aside competitive award with an ultimate completion date of June 30, 2025. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Clarithromycin 500 mg tablets in quantities of 60 units, with a contract ceiling value of $2,393.25. This is a firm fixed-price delivery order with an ultimate completion date of July 18, 2025, and represents a non-competitive set-aside contract. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Clarithromycin 500 mg tablets in 60-count packaging, with a contract ceiling value of $1,991.72. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the...
- The Defense Logistics Agency's Medical Supply Chain awarded a $5.2K delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Clarithromycin 250 mg tablets (60-count units). This non-set-aside, competitively awarded contract employs firm fixed pricing and has an ultimate completion date of September 4, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a child contract...
- The Defense Logistics Agency awarded a $5,427.91 delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Clarithromycin 500 mg tablets (60-count units). This is a firm fixed price contract with an ultimate completion date of June 23, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal healthcare vendor,...
- The U.S. Defense Department's Medical Supply Chain awarded a $2,781.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Clarithromycin 250 mg tablets (60-count packages). The contract, which is not set-aside and was competitively awarded, is scheduled for completion by August 29, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,590.72 to AmerisourceBergen Drug Corp for the supply of Clarithromycin 500 mg tablets (60-count) on September 17, 2025, with completion scheduled for September 18, 2025. The contract utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 2, 2025, by the Defense Logistics Agency (DLA) Medical Supply Chain for $1,859.79 under firm fixed price terms. This competitively awarded, non-set-aside delivery order is scheduled for completion by July 3, 2025, with performance taking place at the vendor's Conshohocken facility. The award represents a child order under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $134,839.30 on September 10, 2025, by the Defense Logistics Agency's Medical Supply Chain. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of September 11, 2025, and represents a child contract under the company's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The award...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKNDUDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency on August 6, 2025, for the supply of Clarithromycin 500 mg tablets (60-count). This firm fixed price delivery order, with a ceiling value of $1,200.82, represents performance through August 7, 2025. The contract award is classified as non-set-aside and competitively awarded, reflecting AmerisourceBergen's capability to meet federal procurement requirements through open competition. The place of performance is located in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and runs through December 2026. This comprehensive pharmaceutical support vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains, serving customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/6/25 |